Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

Published:2010-06-17 Issue:24 Volume:362 Page:2251-2259
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Saglio Giuseppe,Kim Dong-Wook,Issaragrisil Surapol,le Coutre Philipp,Etienne Gabriel,Lobo Clarisse,Pasquini Ricardo,Clark Richard E.,Hochhaus Andreas,Hughes Timothy P.,Gallagher Neil,Hoenekopp Albert,Dong Mei,Haque Ariful,Larson Richard A.,Kantarjian Hagop M.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0912614

Cited by 1430 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events;Molecular Metabolism;2024-10

2. Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer;Journal of Cellular Physiology;2024-09-08

3. Choosing the Best Firstline Drug: Does Efficacy Make You Think About Cost?;Clinical Lymphoma Myeloma and Leukemia;2024-09

4. [Artículo traducido] Asciminib para el tratamiento de la leucemia mieloide crónica en tercera línea: análisis coste-efectividad basado en el enfoque de remisión libre de tratamiento;Farmacia Hospitalaria;2024-09

5. Asciminib for third-line treatment of chronic myeloid leukemia: Cost-effectiveness analysis based on treatment-free remission approach;Farmacia Hospitalaria;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP